Market Focus

Alibaba

Shares of Alibaba have their worst day since going public. The Chinese e-commerce giant’s earnings topped estimates, but revenue missed, disappointing investors. This as the company spent more money trying to attract customers on mobile phones. The company’s executive vice chairman says he still believes there is strong growth potential in mobile. Shares slumped almost nine percent to $89.81.

Ford 

Ford’s report was similar. Its earnings topped estimates, but revenue was slightly below consensus. The automaker maintained its 2015 profit outlook The company also said its loss in Europe would be wider than previously thought for 2015. Still, shares were almost three percent higher to $14.85.

JetBlue

JetBlue’s profit soared in its fourth quarter, as it benefited from lower fuel costs and operating expenses. The airline’s revenue was slightly below estimates, but investors ignored that. Shares rose nearly nine percent to $17.16.

PulteGroup

PulteGroup’s results were better than expected, easily topping the street’s forecast.
The home builder cited a pick up in customer traffic, new orders, closings and a slight increase in average selling prices. Shares popped six percent to $21.82.

Dow Chemical

Dow Chemical, one of the largest chemical companies in the u-s also posted a beat. That’s thanks to growth in its agricultural science business, helped largely by new crop protection products. A stronger dollar did hurts results. Still, shares rose more than 4.5 percent to $45.01.

Hershey

Shares of Hershey melted today after the chocolate maker posted weaker than expected quarterly earnings and cut its 2015 outlook. The company blamed the stronger dollar and rising cocoa and diary prices. Separately, Hershey says it plans to buy Krave Pure Foods a beef jerky maker. Say hello to Hershey jerky. The stock tumbled four percent to $103.29.

Biogen Idec

Biogen Idec out with results after the closing bell, The drug maker’s profit easily topped estimates while revenue was in line. That’s thanks to strong demand for its multiple sclerosis drug. The company also issued a forecast far above consensus. Shares initially jumped after hours. Before the close, shares were up a fraction to $353.25.

This entry was posted in Market Focus. Bookmark the permalink.

Leave a Reply